# Filing Detail

Form PRER14A - Preliminary Proxy Soliciting materials:
SEC Accession No. 0001493152-25-017820
Filing Date
2025-10-10
Accepted
2025-10-10 17:29:05
Documents
6

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRER14A | formprer14a.htm | PRER14A | 1030572
2 | GRAPHIC | formpre14a_001.jpg | GRAPHIC | 5926
3 | GRAPHIC | image_003.jpg | GRAPHIC | 44225
4 | GRAPHIC | image_001.jpg | GRAPHIC | 5830
5 | GRAPHIC | proxy_001.jpg | GRAPHIC | 312754
6 | GRAPHIC | proxy_002.jpg | GRAPHIC | 316861
| Complete submission text file | 0001493152-25-017820.txt |  | 1976486

Mailing Address C/O ANEBULO PHARMACEUTICALS, INC. 1017 RANCH ROAD 620 SOUTH, SUITE 107 LAKEWAY TX 78734
Business Address C/O ANEBULO PHARMACEUTICALS, INC. 1017 RANCH ROAD 620 SOUTH, SUITE 107 LAKEWAY TX 78734 737 203 5270
Anebulo Pharmaceuticals, Inc. (Filer) CIK: 0001815974 (see all company filings)

EIN.: 851170950 | State of Incorp.: DE | Fiscal Year End: 0630
Type: PRER14A | Act: 34 | File No.: 001-40388 | Film No.: 251388828
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)